Literature DB >> 20097157

IMP dehydrogenase is recruited to the transcription complex through serine 2 phosphorylation of RNA polymerase II.

Jae-Hyun Park1, Seong Hoon Ahn.   

Abstract

IMP dehydrogenase (IMPDH) catalyzes the rate-limiting step in the de novo synthesis of guanine, namely the oxidation of IMP to XMP with a concomitant reduction of NAD+. In Saccharomyces cerevisiae, a family of four closely-related genes, IMD1, IMD2 (also known as PUR5), IMD3, and IMD4, encodes the putative IMPDH. Although IMPDH synthesizes guanine in the cytoplasm, it has also been found in the nucleus, where it associates with nucleic acids in human cells. Here, we further show that IMPDH is recruited to actively transcribed region of genes. A synthetic lethal screen using a deletion strain of Ctk1 kinase, a yeast homolog of mammalian Cdk9/P-TEFb that phosphorylates serine 2 within the RNA polymerase II (RNApII) C-terminal domain (CTD), identified that Imd2 genetically interacts with Ctk1. Consistent with this association, IMPDHs were recruited to elongating RNApII only when serine 2 of the CTD was phosphorylated by Ctk1. Loss of Imd2 had little effect on the association of most elongation factors with RNApII. However, in cells lacking Imd2 or all the essential IMPDHs in the presence of minimal guanine, a defect in the association of Ctk1 with the promoter region was seen. Taken together, our results show that IMPDH is recruited to transcription complex through serine 2 phosphorylation of RNApII CTD and suggest that it may play a role in initiating transcriptional regulation. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20097157     DOI: 10.1016/j.bbrc.2010.01.079

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors.

Authors:  L Hedstrom; G Liechti; J B Goldberg; D R Gollapalli
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  Myeloid Leukemia Factor Acts in a Chaperone Complex to Regulate Transcription Factor Stability and Gene Expression.

Authors:  Jamie O Dyer; Arnob Dutta; Madelaine Gogol; Vikki M Weake; George Dialynas; Xilan Wu; Christopher Seidel; Ying Zhang; Laurence Florens; Michael P Washburn; Susan M Abmayr; Jerry L Workman
Journal:  J Mol Biol       Date:  2016-10-27       Impact factor: 5.469

3.  Separate domains of fission yeast Cdk9 (P-TEFb) are required for capping enzyme recruitment and primed (Ser7-phosphorylated) Rpb1 carboxyl-terminal domain substrate recognition.

Authors:  Courtney V St Amour; Miriam Sansó; Christian A Bösken; Karen M Lee; Stéphane Larochelle; Chao Zhang; Kevan M Shokat; Matthias Geyer; Robert P Fisher
Journal:  Mol Cell Biol       Date:  2012-04-16       Impact factor: 4.272

4.  Specific biotinylation of IMP dehydrogenase.

Authors:  B Christopher Hoefler; Deviprasad R Gollapalli; Lizbeth Hedstrom
Journal:  Bioorg Med Chem Lett       Date:  2011-01-14       Impact factor: 2.823

Review 5.  The dynamic determinants of reaction specificity in the IMPDH/GMPR family of (β/α)(8) barrel enzymes.

Authors:  Lizbeth Hedstrom
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-02-15       Impact factor: 8.250

6.  Identification and evaluation of PCR reference genes for host and pathogen in sugarcane-Sporisorium scitamineum interaction system.

Authors:  Ning Huang; Hui Ling; Feng Liu; Yachun Su; Weihua Su; Huaying Mao; Xu Zhang; Ling Wang; Rukai Chen; Youxiong Que
Journal:  BMC Genomics       Date:  2018-06-19       Impact factor: 3.969

Review 7.  IMPDH dysregulation in disease: a mini review.

Authors:  Anika L Burrell; Justin M Kollman
Journal:  Biochem Soc Trans       Date:  2022-02-28       Impact factor: 4.919

Review 8.  Purine-Metabolising Enzymes and Apoptosis in Cancer.

Authors:  Marcella Camici; Mercedes Garcia-Gil; Rossana Pesi; Simone Allegrini; Maria Grazia Tozzi
Journal:  Cancers (Basel)       Date:  2019-09-12       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.